SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
gogogog
Lv3
1
280 积分
2022-10-10 加入
最近求助
最近应助
互助留言
Clinical and Genomic Features of HER2 Exon 20 Insertion Mutations and Characterization of HER2 Expression by Immunohistochemistry in East Asian Non–Small-Cell Lung Cancer
1小时前
已完结
Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study
1小时前
已完结
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
6天前
已完结
Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer
6天前
已完结
Immunotherapy as a partner for HER2-directed therapies
6天前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
7天前
已完结
Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations
8天前
已完结
Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges
8天前
已完结
Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer
11天前
已完结
Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study
13天前
已完结
没有进行任何应助
感谢
1小时前
感谢
1小时前
点赞
5天前
感谢
6天前
感谢
6天前
感谢
7天前
感谢
8天前
感谢
8天前
速度真快
11天前
点赞,帮大忙了
13天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论